Denali Therapeutics Inc. (DNLI) vs Viking Therapeutics, Inc. (VKTX)
A side-by-side comparison of Denali Therapeutics Inc. and Viking Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
DNLI
Denali Therapeutics Inc.
$19.28HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
VKTX
Viking Therapeutics, Inc.
$28.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — DNLI vs VKTX
growth of $100 · dividends reinvested · last 9yDNLI -7.2% (-0.8%/yr)VKTX +691.4% (+25.8%/yr)VKTX compounded faster over this window
Log scale — wide-divergence pair
DNLI VKTX
DNLI vs VKTX: by the numbers
- •VKTX is the larger company ($3.31B vs $3.06B market cap).
- •Both run net losses; VKTX's is the smaller (0.00% vs -14191.20% net margin).
Metrics side by side
Valuation
| Metric | DNLI | VKTX |
|---|---|---|
| P/S ratio | 849.04 | N/A |
| P/B ratio | 3.66 | 8.11 |
Profitability
| Metric | DNLI | VKTX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | -14191.20% | 0.00% |
| ROE | -61.24% | -130.98% |
| ROIC | -50.82% | -135.85% |
Growth (annualized)
| Metric | DNLI | VKTX |
|---|---|---|
| Revenue CAGR (5Y) | 20.68% | N/A |
| Total return CAGR (5Y) | -16.91% | 37.36% |
Frequently asked
- How have DNLI and VKTX total returns compared?
- Over the past 5 years, DNLI delivered -16.91% and VKTX delivered 37.36% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Denali Therapeutics ROEViking Therapeutics ROEDenali Therapeutics operating marginViking Therapeutics operating marginDenali Therapeutics revenue growthViking Therapeutics revenue growthDenali Therapeutics free cash flowViking Therapeutics free cash flow
Denali Therapeutics & Viking Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.